The global Cannabis market was valued at USD 10.4 billion in 2018 and is expected to reach USD 41.9 billion in 2026, growing at a CAGR of 30.5% during the forecast period.Cannabis is related to a whole, unprocessed marijuana plant extracts for the therapy for several illnesses and other associated symptoms. The development of the cannabis industry is driven mainly by the medicinal use and the growing legalization of cannabis are main factors driving the development of this market. However, lack of awareness about the dosage rate and medicinal properties affects that are expected to restraint the growth of the cannabis industry. On the other hand, the increase in the cannabis-based product through research may also provide a profitable chance for market players in the forecasted periods.Based on Product type, concentrates segment expected to dominate the market throughout the forecast period. The global Cannabis market has been segmented flower and concentrates. The concentrates segment is growing rapidly in the Cannabis market with the highest CAGR of 26.9% in the forecast period.This is due to their accessibility and their versatility in the delivery technique, such as ingestible oils, dabbing, and tinctures Apart from ingestion, concentrate can also produce cleaner, smoother and less rancid fragrances than flowers. In addition, the concentration is stronger in nature than the flowers. Based on Application, the medical segment is expected to grow at a CAGR of around 27.1% throughout the forecast periodBased on application, the market has been segmented into recreational and medicinal. The medical type accounts of the largest share in the market and are expected to grow at a CAGR of around 27.1% during the forecast period. The market is driven by the increasing burden of chronic pain illness and the increasing need for efficient worldwide pain management remedies.For instance, according to the World Health Organization (WHO), cancer is the second leading cause of deaths in the world and was responsible for about 8.8 million deaths in 2015. In addition, rising disease burdens of chronic pain and increasing demand for pain management therapies and important side effects connected with opioid use are anticipated to drive demand for medical cannabis.North America to dominate the Cannabis market throughout the forecast periodNorth America accounted for almost 49% of the worldwide market for cannabis in 2018 and is supposed to dominate the market throughout the forecast period. Currently, 33 countries in the U.S. and the District of Colombia have legalized cannabis use in the U.S., making it the biggest market in the globe. In addition, the advent of the New York legal cannabis market will provide further growth possibilities for stakeholders in the nation. The presence of large client base and legalization marijuana in the U.S. and Canada is expected to increase demand for cannabis-based products from North America.The cannabis industry is further fuelled by the presence of important cannabis companies such as Aurora Cannabis Inc. Canopy Growth Corporation, and Medical Marijuana Inc., these companies are continuously investing in research & development and collaborating with strategic agreements to come up with new products to address customer demand. Company Profiles and Competitive Intelligence:The major players operating in the global Cannabis market are Canopy Growth Corporation, Aurora Cannabis Inc., Tikun Olam, Cannabis Science Inc., Aphria Inc., Maricann Group Inc., Tilray Inc., VIVO Cannabis Inc., Medical Marijuana, Inc., STENOCARE, Cronos Group Inc., and among others.
Summary: Get latest Market Research Reports on Cannabis. Industry analysis & Market Report on Cannabis is a syndicated market report, published as Global Cannabis Market - Segment Analysis, Opportunity Assessment, Competitive Intelligence, Industry Outlook 2016-2026. It is complete Research Study and Industry Analysis of Cannabis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.